Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Research Area
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
PA-8 is a pituitary adenylate cyclase-activating peptide (PACAP) type 1 (PAC1) receptor antagonist.1 It selectively inhibits PACAP-induced CREB phosphorylation in CHO cells expressing the PAC1 receptor over CHO cells expressing vasoactive intestinal polypeptide receptor 1 (VPAC1) or VPAC2 at 10 nM. PA-8 inhibits PACAP-induced cAMP accumulation in CHO cells expressing the PAC1 receptor (IC50 = 2 nM). Intrathecal administration of PA-8 (100 pmol/animal) reduces PACAP-induced transient aversive behaviors and mechanical allodynia in mice.
WARNING This product is not for human or veterinary use.
1. In silico screening identified novel small-